Trial intelligence / Profile preview

N-Acetylcysteine for Overt Diabetic Nephropathy

NCT00556465Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acetylcysteine in diabetic nephropathy (DN), sponsored by Shiraz University of Medical Sciences. Started Jan 2007; status: completed.

02

Drugs

acetylcysteine
03

Conditions

diabetic nephropathy (DN)

Beyond the preview

Go deeper on NCT00556465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00556465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call